Clinical Trial Detail

NCT ID NCT01523977
Title Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Dana-Farber Cancer Institute
Indications

acute lymphocytic leukemia

Therapies

Prednisone

Everolimus

Vincristine

Doxorubicin

Pegaspargase

Age Groups: child

Additional content available in CKB BOOST